Clinical Trial Update: S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC) [NA]

View source ↗

Summary

This clinical trial update reports an active-not-recruiting study evaluating S-adenosylmethionine (SAMe) in patients with primary sclerosing cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• S-adenosylmethionine (SAMe) (S-adenosyl-L-methionine)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Primary Sclerosing Cholangitis (PSC) | NA | Status: ACTIVE_NOT_RECRUITING